Please enable JavaScript to continue using this application.

Compare $EXOZ vs $KLRS | Chartloom

Compare

$EXOZ vs $KLRS

eXoZymes Inc · Kalaris Therapeutics Inc

EXOZ

eXoZymes Inc

KLRS

Kalaris Therapeutics Inc

Compare $EXOZ vs $KLRS

Comparing eXoZymes Inc and Kalaris Therapeutics Inc

EXOZeXoZymes Inc

KLRSKalaris Therapeutics Inc

EXOZeXoZymes Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-52.2%

52W performance

-66.1%

FCF yield

-14.7%

KLRSKalaris Therapeutics Inc

Market cap

$56M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-71.6%

52W performance

-64.2%

FCF yield

-73.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EXOZ

KLRS

Detailed metrics comparison

EXOZ

eXoZymes Inc

KLRS

Kalaris Therapeutics Inc

Market Cap

EXOZ$49M

KLRS$56M

Enterprise Value

EXOZ$43M

KLRS$45M

Price

EXOZ$5.25

KLRS$2.36

P/E Ratio

EXOZN/A

KLRSN/A

P/S Ratio

EXOZ0.00x

KLRS0.00x

EV/Sales

EXOZ0.00x

KLRS0.00x

EV/EBITDA

EXOZ0.00x

KLRS0.00x

P/B Ratio

EXOZ14.66x

KLRS1.02x

P/FCF Ratio

EXOZN/A

KLRSN/A

EV/FCF

EXOZ-6.04x

KLRS-1.09x

PEG Ratio

EXOZN/A

KLRSN/A

Forward P/E (NTM)

EXOZN/A

KLRSN/A

Forward P/S (NTM)

EXOZN/A

KLRSN/A

Revenue (TTM)

EXOZ$0

KLRS$0

Revenue Growth (YoY)

EXOZN/A

KLRSN/A

Forward Rev Growth

EXOZ0.0%

KLRS180.3%

Gross Margin (TTM)

EXOZ0.0%

KLRS0.0%

Operating Margin (TTM)

EXOZ0.0%

KLRS0.0%

EBITDA Margin (TTM)

EXOZ0.0%

KLRS0.0%

Net Margin (TTM)

EXOZ0.0%

KLRS0.0%

FCF Margin (TTM)

EXOZN/A

KLRSN/A

Net Income (TTM)

EXOZ$-10M

KLRS$-44M

FCF (TTM)

EXOZ$-7M

KLRS$-41M

EPS (TTM)

EXOZ-$1.18

KLRS-$1.86

ROE (TTM)

EXOZ-29213.0%

KLRS-7171.0%

ROA (TTM)

EXOZ-15866.0%

KLRS-4295.0%

ROIC (TTM)

EXOZ-28374.0%

KLRS-4719.0%

Cash

EXOZ$6M

KLRS$43M

Debt

EXOZ$87K

KLRS$32M

Net Cash/Debt

EXOZ$6M

KLRS$11M

Current Ratio (TTM)

EXOZ3.81x

KLRS10.98x

Quick Ratio (TTM)

EXOZ3.63x

KLRS10.76x

Debt/Equity (TTM)

EXOZ0.02x

KLRS0.56x

Debt/Assets (TTM)

EXOZ0.0%

KLRS0.0%

Interest Coverage (TTM)

EXOZN/A

KLRSN/A

Net Debt/EBITDA (TTM)

EXOZ0.00x

KLRS0.00x

Beta

EXOZ1.20

KLRS0.44

52W Performance

EXOZ-66.1%

KLRS-64.2%

YTD Performance

EXOZ-52.2%

KLRS-71.6%

% from 52W High

EXOZ-71.5%

KLRS-80.1%

% from 52W Low

EXOZ20.7%

KLRS0.4%

Asset Turnover (TTM)

EXOZ0.00x

KLRS0.00x

FCF Yield (TTM)

EXOZ-14.7%

KLRS-73.4%

Earnings Yield (TTM)

EXOZ-20.9%

KLRS-78.8%

Dividend Yield (TTM)

EXOZN/A

KLRSN/A

Rule of 40

EXOZ0.0

KLRS0.0

EV/GP/RG

EXOZN/A

KLRSN/A

Ticker research

View EXOZ research View KLRS research

Metric	EXOZ eXoZymes Inc	KLRS Kalaris Therapeutics Inc
Market & Valuation
Market Cap	$49M	$56M
Enterprise Value	$43M	$45M
Price	$5.25	$2.36
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	14.66x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.04x	-1.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	180.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-44M
FCF (TTM)	$-7M	$-41M
EPS (TTM)	-$1.18	-$1.86
ROE (TTM)	-29213.0%	-7171.0%
ROA (TTM)	-15866.0%	-4295.0%
ROIC (TTM)	-28374.0%	-4719.0%
Financial Health
Cash	$6M	$43M
Debt	$87K	$32M
Net Cash/Debt	$6M	$11M
Current Ratio (TTM)	3.81x	10.98x
Quick Ratio (TTM)	3.63x	10.76x
Debt/Equity (TTM)	0.02x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	0.44
52W Performance	-66.1%	-64.2%
YTD Performance	-52.2%	-71.6%
% from 52W High	-71.5%	-80.1%
% from 52W Low	20.7%	0.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-14.7%	-73.4%
Earnings Yield (TTM)	-20.9%	-78.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EXOZ research	View KLRS research

Valuation

P/S Ratio

EXOZ

0.00x

KLRS

0.00x

EV/FCF

EXOZ

-6.04x

KLRS

-1.09x

Growth & revenue

Forward Revenue Growth

KLRS

180.3%

EXOZ

0.0%

Profitability & performance

Gross Margin

EXOZ

0.0%

KLRS

0.0%

ROE

KLRS

-7171.0%

EXOZ

-29213.0%

FCF Yield %

EXOZ

-14.7%

KLRS

-73.4%

52-Week Performance

KLRS

-64.2%

EXOZ

-66.1%

Detailed metrics comparison

EXOZ

eXoZymes Inc

KLRS

Kalaris Therapeutics Inc

Market Cap

EXOZ$49M

KLRS$56M

Enterprise Value

EXOZ$43M

KLRS$45M

Price

EXOZ$5.25

KLRS$2.36

P/E Ratio

EXOZN/A

KLRSN/A

P/S Ratio

EXOZ0.00x

KLRS0.00x

EV/Sales

EXOZ0.00x

KLRS0.00x

EV/EBITDA

EXOZ0.00x

KLRS0.00x

P/B Ratio

EXOZ14.66x

KLRS1.02x

P/FCF Ratio

EXOZN/A

KLRSN/A

EV/FCF

EXOZ-6.04x

KLRS-1.09x

PEG Ratio

EXOZN/A

KLRSN/A

Forward P/E (NTM)

EXOZN/A

KLRSN/A

Forward P/S (NTM)

EXOZN/A

KLRSN/A

Revenue (TTM)

EXOZ$0

KLRS$0

Revenue Growth (YoY)

EXOZN/A

KLRSN/A

Forward Rev Growth

EXOZ0.0%

KLRS180.3%

Gross Margin (TTM)

EXOZ0.0%

KLRS0.0%

Operating Margin (TTM)

EXOZ0.0%

KLRS0.0%

EBITDA Margin (TTM)

EXOZ0.0%

KLRS0.0%

Net Margin (TTM)

EXOZ0.0%

KLRS0.0%

FCF Margin (TTM)

EXOZN/A

KLRSN/A

Net Income (TTM)

EXOZ$-10M

KLRS$-44M

FCF (TTM)

EXOZ$-7M

KLRS$-41M

EPS (TTM)

EXOZ-$1.18

KLRS-$1.86

ROE (TTM)

EXOZ-29213.0%

KLRS-7171.0%

ROA (TTM)

EXOZ-15866.0%

KLRS-4295.0%

ROIC (TTM)

EXOZ-28374.0%

KLRS-4719.0%

Cash

EXOZ$6M

KLRS$43M

Debt

EXOZ$87K

KLRS$32M

Net Cash/Debt

EXOZ$6M

KLRS$11M

Current Ratio (TTM)

EXOZ3.81x

KLRS10.98x

Quick Ratio (TTM)

EXOZ3.63x

KLRS10.76x

Debt/Equity (TTM)

EXOZ0.02x

KLRS0.56x

Debt/Assets (TTM)

EXOZ0.0%

KLRS0.0%

Interest Coverage (TTM)

EXOZN/A

KLRSN/A

Net Debt/EBITDA (TTM)

EXOZ0.00x

KLRS0.00x

Beta

EXOZ1.20

KLRS0.44

52W Performance

EXOZ-66.1%

KLRS-64.2%

YTD Performance

EXOZ-52.2%

KLRS-71.6%

% from 52W High

EXOZ-71.5%

KLRS-80.1%

% from 52W Low

EXOZ20.7%

KLRS0.4%

Asset Turnover (TTM)

EXOZ0.00x

KLRS0.00x

FCF Yield (TTM)

EXOZ-14.7%

KLRS-73.4%

Earnings Yield (TTM)

EXOZ-20.9%

KLRS-78.8%

Dividend Yield (TTM)

EXOZN/A

KLRSN/A

Rule of 40

EXOZ0.0

KLRS0.0

EV/GP/RG

EXOZN/A

KLRSN/A

Ticker research

View EXOZ research View KLRS research

Metric	EXOZ eXoZymes Inc	KLRS Kalaris Therapeutics Inc
Market & Valuation
Market Cap	$49M	$56M
Enterprise Value	$43M	$45M
Price	$5.25	$2.36
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	14.66x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.04x	-1.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	180.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-44M
FCF (TTM)	$-7M	$-41M
EPS (TTM)	-$1.18	-$1.86
ROE (TTM)	-29213.0%	-7171.0%
ROA (TTM)	-15866.0%	-4295.0%
ROIC (TTM)	-28374.0%	-4719.0%
Financial Health
Cash	$6M	$43M
Debt	$87K	$32M
Net Cash/Debt	$6M	$11M
Current Ratio (TTM)	3.81x	10.98x
Quick Ratio (TTM)	3.63x	10.76x
Debt/Equity (TTM)	0.02x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	0.44
52W Performance	-66.1%	-64.2%
YTD Performance	-52.2%	-71.6%
% from 52W High	-71.5%	-80.1%
% from 52W Low	20.7%	0.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-14.7%	-73.4%
Earnings Yield (TTM)	-20.9%	-78.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EXOZ research	View KLRS research